JORDAN VERRALL: Open Payments
NPI 1902578313 · WILLIAMSVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,544 in 87 payments from 18 companies in 2025. Trend: 2023 $738 · 2024 $646 · 2025 $1,544
Food & beverage: $1,544
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 16 | $298 |
| Janssen Biotech, Inc. | 16 | $239 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 14 | $193 |
| ABBVIE INC. | 9 | $140 |
| Exact Sciences Corporation | 5 | $106 |
| Novo Nordisk Inc | 5 | $97 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $81 |
| Madrigal Pharmaceuticals | 2 | $66 |
| Aimmune Therapeutics, Inc. | 3 | $65 |
| AstraZeneca Pharmaceuticals LP | 3 | $56 |
Products named: TREMFYA, XIFAXAN, OMVOH, MOUNJARO, RINVOQ, REZDIFFRA, ZENPEP, ENTYVIO.
Industry payments across NY — which companies pay providers there.
